Eric B Thorndike
Overview
Explore the profile of Eric B Thorndike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chojnacki M, Thorndike E, Partilla J, Rice K, Schindler C, Baumann M
J Pharmacol Exp Ther
. 2023 Jan;
385(3):162-170.
PMID: 36669877
Synthetic cathinones are a class of new psychoactive substances that display psychomotor stimulant properties, and novel cathinone analogs continue to emerge in illicit drug markets worldwide. The aim of the...
2.
McGriff S, Chojnacki M, Thorndike E, Rice K, Baumann M, Schindler C
Psychopharmacology (Berl)
. 2022 Oct;
239(11):3723-3730.
PMID: 36190536
Rationale: Synthetic phenethylamine (PEA) analogs, such as β-methylphenethylamine (BMPEA) and N,α-diethylphenethylamine (DEPEA), are often found in dietary supplements, despite regulations prohibiting their sale. PEA analogs are structurally related to amphetamine,...
3.
Schindler C, Thorndike E, Partilla J, Rice K, Baumann M
J Pharmacol Exp Ther
. 2020 Oct;
376(1):118-126.
PMID: 33082158
Dietary supplements often contain additives not listed on the label, including -ethyl homologs of amphetamine such as ,-diethylphenethylamine (DEPEA). Here, we examined the neurochemical and cardiovascular effects of -ethylphenethylamine (AEPEA),...
4.
Schindler C, Thorndike E, Walters H, Walther D, Rice K, Baumann M
Addict Biol
. 2019 Nov;
25(6):e12842.
PMID: 31724254
The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP) continues to be abused despite being banned by regulatory agencies. The abused formulation of α-PVP is a racemic mixture consisting of two enantiomers, S-α-PVP and...
5.
Jordan C, Humburg B, Thorndike E, Shaik A, Xi Z, Baumann M, et al.
J Pharmacol Exp Ther
. 2019 Sep;
371(3):602-614.
PMID: 31562201
Opioid and cocaine abuse are major public health burdens. Existing medications for opioid use disorder are limited by abuse liability and side effects, whereas no treatments are currently approved in...
6.
Schindler C, Thorndike E, Rice K, Partilla J, Baumann M
J Pharmacol Exp Ther
. 2019 Mar;
369(3):328-336.
PMID: 30898867
-Methylphenethylamine [(BMPEA), 2-phenylpropan-1-amine] is a structural isomer of amphetamine (1-phenylpropan-2-amine) that has been identified in preworkout and weight loss supplements, yet little information is available about its pharmacology. Here, the...
7.
Schindler C, Gramling B, Justinova Z, Thorndike E, Baumann M
Drug Alcohol Depend
. 2017 Aug;
179:387-394.
PMID: 28846955
Background: The misuse of synthetic cannabinoids is a persistent public health concern. Because these drugs target the same cannabinoid receptors as the active ingredient of marijuana, Δ-tetrahydrocannabinol (THC), we compared...
8.
Secci M, Auber A, Panlilio L, Redhi G, Thorndike E, Schindler C, et al.
Neuropsychopharmacology
. 2017 Feb;
42(8):1619-1629.
PMID: 28139681
The currently available antismoking medications have limited efficacy and often fail to prevent relapse. Thus, there is a pressing need for newer, more effective treatment strategies. Recently, we demonstrated that...
9.
Schindler C, Thorndike E, Suzuki M, Rice K, Baumann M
Br J Pharmacol
. 2016 Oct;
173(24):3492-3501.
PMID: 27714779
Background And Purpose: 3,4-Methylenedioxypyrovalerone (MDPV) is a synthetic cathinone with stimulatory cardiovascular effects that can lead to serious medical complications. Here, we examined the pharmacological mechanisms underlying these cardiovascular actions...
10.
Panlilio L, Thorndike E, Nikas S, Alapafuja S, Bandiera T, Cravatt B, et al.
Psychopharmacology (Berl)
. 2015 Nov;
233(10):1879-88.
PMID: 26558620
Rationale: Manipulations of the endocannabinoid system could potentially produce therapeutic effects with minimal risk of adverse cannabis-like side effects. Inhibitors of fatty acid amide hydrolase (FAAH) increase endogenous levels of...